CAG
48
2
UPS
55
4
MAT
43
-2
PEP
54
3
OKE
67
2
CLX
50
4
PCG
94
11
NEM
48
-4
GM
82
2
JBHT
42
2
V
70
-2
DE
30
-10
WMT
75
13
EXPE
50
3
CNP
68
3
CHD
64
-3
DRI
61
-2
HBAN
54
-3
TXT
70
-3
ABT
48
3
CAG
48
2
UPS
55
4
MAT
43
-2
PEP
54
3
OKE
67
2
CLX
50
4
PCG
94
11
NEM
48
-4
GM
82
2
JBHT
42
2
V
70
-2
DE
30
-10
WMT
75
13
EXPE
50
3
CNP
68
3
CHD
64
-3
DRI
61
-2
HBAN
54
-3
TXT
70
-3
ABT
48
3
Financhill
Back

Biodexa Pharmaceuticals Plc 10K Form

Sell
50

BDRX
Biodexa Pharmaceuticals Plc

Last Price:
1.18
Seasonality Move:
-23.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDRX News And Ratings

See the #1 stock for the next 7 days that we like better than BDRX

BDRX Financial Statistics

Sales & Book Value

Annual Sales: $474.09K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $2.00
Price / Book: 0.91

Profitability

EPS (TTM): -402.00030
Net Income (TTM): $-8.83M
Gross Margin: $-4.59M
Return on Equity: -160.77%
Return on Assets: -87.8%

Biodexa Pharmaceuticals Plc Earnings Forecast

Key Biodexa Pharmaceuticals Plc Financial Ratios

  • The Gross Profit Margin over the past 11 years for BDRX is -967.45%.
  • The Selling, General & Administrative Expenses for BDRX have been equal to 1,139.63% of Gross Profit Margin.
  • The Interest Expense is -0.58% of Operating Income.
  • The Net Earning history of BDRX is -1,857.99% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 7 years.

Biodexa Pharmaceuticals Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDRX
Website: biodexapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.26
Quick Ratio: 1.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDRX Technical Analysis vs Fundamental Analysis

Sell
50
Biodexa Pharmaceuticals Plc (BDRX) is a Sell

Is Biodexa Pharmaceuticals Plc a Buy or a Sell?